Table 1 -.

ESTROGEN DOSES IN COMBINED ORAL CONTRACEPTIVES AND RELATIVE RISK OF VTE

Meta-analysis	Studies includd		Non user	LNG/EE 20	LNG/EE 30–40	LNG/EE 50	DSG/EE 20	DSG/EE 30–40	GSD/EE 20	GSD/EE 30–40
Oedingen 2018[41]	11 case control studies 6 cohort studies	RR (95 % CI)	-	-	1		1.46 (1.33–1.59)	1.39 (1.16–1.67)	1.18 (0.93–1.49)	1.27 (1.15–1.41)
De Bastos 2014 [83]	9 cohort studies 17 case control studies	RR (95 % CI)	1	2.2 (1.2–3.6)	2.4 (1.8–3.2)	5.2 (3.4–7.9)	3.4 (2.5–4.6)	3.7 (2.8–4.9)	2.2 (1.4–3.2)	3.7 (2.8–4.9)

LNG - Levonorgestrel

DSG - Desogestrel

GSD - Gestodene

EE 20 - Ethinyl estrasdiol 20 micrograms

EE 30–40 - Ethinyl estradiol 30–40 micrograms

EE 50 - Ethinyl estradiol 50 micrograms